Dolby Laboratories (NYSE: DLB) reported Q4 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $285 million versus the consensus estimate of $299.95 million.

GUIDANCE:

Dolby Laboratories sees Q1 2022 EPS of $0.98-$1.13, versus the consensus of $1.31. Dolby Laboratories sees Q1 2022 revenue of $345-375 million, versus the consensus of $389 million.

Dolby Laboratories sees FY2022 EPS of $3.52-$4.02, versus the consensus of $3.94. Dolby Laboratories sees FY2022 revenue of $1.34-1.4 million, versus the consensus of $1.37 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.